» Articles » PMID: 24574651

Cyclin D1 an Early Biomarker in Oral Carcinogenesis

Overview
Date 2014 Feb 28
PMID 24574651
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Dysregulation of cell cycle is a fundamental hallmark of cancer progression. Cyclin D1, part of complex molecular system regulating G1-S point of cell cycle is overexpressed in variety of tumors.

Aims: To look for its immunohistochemical expression in clinically normal mucosa from patients with and without tobacco habits, leukoplakia; and correlate its expression to individual atypical morphologic features, as seen in hematoxylin and eosin (H and E) sections of leukoplakia exhibiting dysplasia.

Materials And Methods: We examined the expression of cyclin D1 in immunohistochemically stained sections of 15 normal buccal mucosa without any habits (group 1), 30 clinically normal mucosa from tobacco habituιs (group 2) and 30 leukoplakias exhibiting dysplasias (group 3). Descriptive statistical analysis performed. Results presented on Mean ± Standard deviation and in number (%). Adjusted Wald 95% Confidence Interval (CI) computed, percentages of morphological features assessed by Laplace estimate. Mann-Whitney U, Kruskal-Wallis test used to find the percentage expression of cyclin D1.

Results: Expression of cyclin D1 in group 3 was significantly higher than in group 1 and 2 (P < 0.001, P = 0.028), expression in group 2 was significantly higher than in group 1 (P = 0.003) and were statistically significant. Generally expression of cyclin D1 was confined to lower one-third of epithelium and was highest in mild dysplasias. Among 13 atypical morphologic features, cyclin D1 expression consistently correlated with basilar hyperplasia.

Conclusion: The altered pattern of cyclin D1 expression here may be an early event in conversion of normal epithelium into dysplastic epithelium and may serve as a biomarker of oral carcinogenesis. Its expression may be increased in tobacco habitués. Basilar hyperplasia should be given additional weightage in the grading system in predicting the fate of affected epithelium.

Citing Articles

Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma.

Xiang Y, Yang Y, Liu J, Yang X Front Oncol. 2023; 13:1219211.

PMID: 37404761 PMC: 10315918. DOI: 10.3389/fonc.2023.1219211.


Proliferation and Apoptosis Pathways and Factors in Oral Squamous Cell Carcinoma.

He S, Chakraborty R, Ranganathan S Int J Mol Sci. 2022; 23(3).

PMID: 35163485 PMC: 8836072. DOI: 10.3390/ijms23031562.


Clinical significance of activated Wnt/β-catenin signaling in apoptosis inhibition of oral cancer.

Wang Y, Cao Z, Liu F, Ou Y Open Life Sci. 2021; 16(1):1045-1052.

PMID: 34632073 PMC: 8480266. DOI: 10.1515/biol-2021-0104.


Prognostic significance of E-Cadherin, β-Catenin and cyclin D1 in oral squamous cell carcinoma: a tissue microarray study.

Al-Rawi N, Al Ani M, Quadri A, Hamdoon Z, Awwad A, Al Kawas S Histol Histopathol. 2021; 36(10):1073-1083.

PMID: 34309825 DOI: 10.14670/HH-18-363.


Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring.

Chaudhary S, Pothuraju R, Rachagani S, Siddiqui J, Atri P, Mallya K Cancer Lett. 2021; 510:79-92.

PMID: 33878394 PMC: 8153085. DOI: 10.1016/j.canlet.2021.04.004.


References
1.
Liu S, Sauter E, Clapper M, FELDMAN R, Levin L, Chen S . Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity. Cancer Epidemiol Biomarkers Prev. 1998; 7(7):597-603. View

2.
Serrano M, Hannon G, Beach D . A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993; 366(6456):704-7. DOI: 10.1038/366704a0. View

3.
Reibel J . Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med. 2003; 14(1):47-62. DOI: 10.1177/154411130301400105. View

4.
Scully C . Oral precancer: preventive and medical approaches to management. Eur J Cancer B Oral Oncol. 1995; 31B(1):16-26. DOI: 10.1016/0964-1955(94)00049-a. View

5.
Scully C, Field J, Tanzawa H . Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations. Oral Oncol. 2000; 36(4):311-27. DOI: 10.1016/s1368-8375(00)00021-x. View